Free Cash Flow Chart

View Free Cash Flow for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 11.44B
March 31, 2026 11.91B
December 31, 2025 12.84B
September 30, 2025 15.30B
June 30, 2025 14.58B
March 31, 2025 13.09B
December 31, 2024 13.94B
September 30, 2024 13.80B
June 30, 2024 12.94B
March 31, 2024 12.51B
December 31, 2023 12.65B
September 30, 2023 11.69B
June 30, 2023 10.72B
March 31, 2023 11.08B
December 31, 2022 11.95B
September 30, 2022 12.72B
June 30, 2022 14.28B
March 31, 2022 15.14B
December 31, 2021 15.23B
September 30, 2021 14.88B
June 30, 2021 11.95B
March 31, 2021 13.24B
December 31, 2020 13.30B
September 30, 2020 11.70B
June 30, 2020 12.00B
Date Value
March 31, 2020 9.753B
December 31, 2019 7.231B
September 30, 2019 7.583B
June 30, 2019 6.272B
March 31, 2019 5.239B
December 31, 2018 4.989B
September 30, 2018 3.713B
June 30, 2018 4.109B
March 31, 2018 4.586B
December 31, 2017 4.22B
September 30, 2017 4.414B
June 30, 2017 4.019B
March 31, 2017 2.833B
December 31, 2016 1.635B
September 30, 2016 904.00M
June 30, 2016 138.00M
March 31, 2016 -106.00M
December 31, 2015 1.012B
September 30, 2015 1.067B
June 30, 2015 1.573B
March 31, 2015 2.613B
December 31, 2014 2.622B
September 30, 2014 3.451B
June 30, 2014 3.584B
March 31, 2014 4.05B

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Johnson & Johnson 22.61B
Eli Lilly & Co. 13.56B
Merck & Co., Inc. 16.06B
Pfizer Inc. 10.99B
AstraZeneca PLC 8.051B